Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer.
about
Squalene epoxidase, located on chromosome 8q24.1, is upregulated in 8q+ breast cancer and indicates poor clinical outcome in stage I and II diseaseYoung age: an independent risk factor for disease-free survival in women with operable breast cancerCompliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experienceGene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.Mapping lymph nodes in cancer management - role of (99m)Tc-tilmanocept injectionPlasminogen Activator System and Breast Cancer: Potential Role in Therapy Decision Making and Precision MedicineThe MINDACT trial: the first prospective clinical validation of a genomic toolQuantitative analysis of the anti-proliferative activity of combinations of selected iron-chelating agents and clinically used anti-neoplastic drugsCCNA2 is a prognostic biomarker for ER+ breast cancer and tamoxifen resistanceDescriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence.Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.Design of superparamagnetic nanoparticles for magnetic particle imaging (MPI).Is primary surgery of breast cancer patients consistent with German guidelines? Twelve-year trend of population-based clinical cancer registry data.Detection of mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: interim results of a prospective cohort study.Survival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas.Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithmsTrastuzumab monotherapy for bone marrow metastasis of breast cancer: A case report.Methylated DNA and high total DNA levels in the serum of patients with breast cancer following neoadjuvant chemotherapy are predictive of a poor prognosis.Magnetic resonance imaging shrinkage patterns following neoadjuvant chemotherapy for breast carcinomas with an emphasis on the radiopathological correlationsBreast cancer before age 40 years.A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients.Tamoxifen plus tegafur-uracil (TUFT) versus tamoxifen plus Adriamycin (doxorubicin) and cyclophosphamide (ACT) as adjuvant therapy to treat node-positive premenopausal breast cancer (PreMBC): results of Japan Clinical Oncology Group Study 9404Predictors and outcomes of surgeons' referral of older breast cancer patients to medical oncologistsGene expression signature in organized and growth-arrested mammary acini predicts good outcome in breast cancerPrognosis of lymph node-negative breast cancer: Association with clinicopathological factors and tumor associated gene expressionA web-based system for individualised survival estimation in breast cancer.The expanding role of epirubicin in the treatment of breast cancer.Potential therapeutic mechanism of genistein in breast cancer involves inhibition of cell cycle regulation.Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort.Postoperative endocrine therapy for invasive breast cancer.Foxo3a expression is a prognostic marker in breast cancer.The specialist breast unit and breast surgery as a specialty.Prognostic influence of age at diagnosis in premenopausal breast cancer patients.Can positron emission tomography/computed tomography with the dual tracers fluorine-18 fluoroestradiol and fluorodeoxyglucose predict neoadjuvant chemotherapy response of breast cancer?--A pilot study.Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions.Guideline conformity treatment in young women with early-onset breast cancer in GermanyMagnetic resonance metabolic profiling of breast cancer tissue obtained with core needle biopsy for predicting pathologic response to neoadjuvant chemotherapyAdjuvant ovarian suppression in premenopausal breast cancer.uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies.Influence of Androgen Receptor Expression on the Survival Outcomes in Breast Cancer: A Meta-Analysis
P2860
Q24655384-3C943A54-EF56-45D7-BBB2-247705D6CB43Q24791855-EB4B4FB9-570D-4542-91E8-8C277033D18BQ24792539-A9942D85-D7BC-429E-99A6-415E18C80AC7Q25257621-AF003A8E-C756-4B73-8B1D-4910DA739CF9Q27022042-A119EB0F-C630-455B-9E59-0970E7102E35Q28067626-8B6EB74A-420A-4325-9BCD-9DCCA5860C1BQ28242008-6AFAF37F-2092-4940-91E4-81009922456FQ28539989-D6C25B31-0DCA-486F-98DF-A82D607ADF7DQ28540790-2192E41B-C8CF-47AC-A88C-E256E006666FQ30248287-A3105A59-42FD-41BB-BCA3-C369AF17CBECQ30313653-12C0A558-8171-4B40-8E1D-B27C42750566Q30448145-A5B063A4-FFD8-4168-B661-0E08B673B5FDQ30789643-822D48A0-B363-464C-96D9-DE037EEA8A58Q33320704-1E3265E5-25C8-4581-9E9F-F27A8A095DFAQ33587519-4C968668-418F-4F72-88FE-E3CF66420FDBQ33651520-B8DC340D-F0B1-4E02-ACAB-6AFA618FB92FQ33727704-875A5424-D77C-4C2E-9368-0B940BF233B3Q33778433-73098960-F43A-4B31-A2DD-830852C04169Q33933029-880E2A6F-5771-4878-92CE-EA823AF3173BQ33948726-95949C53-B88D-4551-901E-22F4AFDA59F3Q33996270-084E9F5F-118E-4254-BF09-7899E66EE061Q34085163-B033D008-BD33-4D04-ABBC-D17F4A3F2C82Q34099121-E6C256C4-22A1-44A6-9B4B-417F28788776Q34103462-AF82B301-3FB2-49E5-A75C-1FB15028415CQ34141617-F62329FB-65FF-493C-BFE1-B4FE7BA749A0Q34434198-F01D8933-374D-4D2B-89E2-3BC4CD5D29B6Q34608626-FD5A8C0C-109D-48A1-A8CC-941B29B4AE9EQ34731241-3E02A7FB-7E7C-4311-AFC5-0CDC82227F6DQ34778940-A3C9B9B6-06F3-4F56-9E07-2A08662C6D15Q34910095-A991878F-98B2-49F9-B910-BE9B5B6CD99AQ34962718-51201CF4-2E68-4729-8D93-77A0AA8F637BQ35008154-4D4DA85A-12E2-48C6-B473-9B534093568FQ35008202-152766F4-E664-4238-AE5D-7D6B79589802Q35036174-39C5AC79-1A38-46D5-BE58-8B21493E31BDQ35060342-40545CC8-A836-4943-A3C5-4CE05315059BQ35066948-F3809B45-A2A6-4893-BF5C-A896D6391294Q35075617-0BBE0C15-43AC-4317-B258-7AE578D1C121Q35124558-75DA7C5B-4625-41FA-A3F6-F856555B831EQ35580701-313D1C81-FAF0-4715-9AA8-4FE3C02F06B6Q35686249-210CC7D6-7284-4567-8C6C-25E669A9440F
P2860
Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Meeting highlights: Internatio ...... rapy of Primary Breast Cancer.
@ast
Meeting highlights: Internatio ...... rapy of Primary Breast Cancer.
@en
Meeting highlights: Internatio ...... rapy of Primary Breast Cancer.
@nl
type
label
Meeting highlights: Internatio ...... rapy of Primary Breast Cancer.
@ast
Meeting highlights: Internatio ...... rapy of Primary Breast Cancer.
@en
Meeting highlights: Internatio ...... rapy of Primary Breast Cancer.
@nl
prefLabel
Meeting highlights: Internatio ...... rapy of Primary Breast Cancer.
@ast
Meeting highlights: Internatio ...... rapy of Primary Breast Cancer.
@en
Meeting highlights: Internatio ...... rapy of Primary Breast Cancer.
@nl
P2093
P1476
Meeting highlights: Internatio ...... rapy of Primary Breast Cancer.
@en
P2093
A Goldhirsch
A S Coates
R D Gelber
P304
P356
10.1200/JCO.2001.19.18.3817
P407
P577
2001-09-01T00:00:00Z